Skip to main content
. 2020 Jul;21(7):1977–1986. doi: 10.31557/APJCP.2020.21.7.1977

Table 2.

Percentage of Cell Viability and Inhibition of HeLa, SiHa and CaSki Cell Lines by EAE at 24h Calculated IC50 value

Concentration of EAE (µg/mL) Cell viability ± SD (%)
Inhibition± SD (%)
IC50± SD value of EAE
HeLa SiHa CaSki HeLa SiHa CaSki HeLa SiHa CaSki
50 84.33±7.67b 89.85±8.08b 90.88±9.56b 15.67±2.11f 10.15±1.86e 9.12±1.06f 204.14±17.45 254.56±20.11 262.01±22.78
100 76.77±6,99c 81.33±7.78c 84.88±7.90bc 23.23±2.98e 18.67±1.90d 15.12±2.52e
150 58.44±5.45d 65.84±5.23d 72.22±6.98c 41.56±3.79d 34.16±3.12c 27.78±2.67d
200 50.45±5.21d 55.12±4.10e 65.55± 6.55d 49.54±4.11c 44.78±4.16b 34.45±3.56c
250 43.99±3.12e 50.44±4.34e 54.89±5.63e 56.01±4.92b 49.56±5.23b 45.11±4.21b
Control (negative) 100a 100a 100a 0 0 0
Positive control (Adriamycin 5 µg/mL) 1.91±0.41f 2.44±0.52f 2.92±0.71f 98.19±11.45a 97.56±10.12a 97.08±11.79a

Note: Each data is Mean± SD (p<0.05) of three independent experiments. Same letter in the same row indicates statistically no different but different letter indicates they are statistically different as per Duncan analysis (p=0.05 level)